FDA Reviewing Safety Of Lilly Sepsis Drug Xigris

WASHINGTON -(Dow Jones)- The Food and Drug Administration is conducting a safety review of an Eli Lilly & Co. (LLY) drug used to treat severe sepsis after a recent study suggested the drug could increase the risk of serious bleeding and death. In a...